Please login to the form below

Not currently logged in
Email:
Password:

legal action

This page shows the latest legal action news and features for those working in and with pharma, biotech and healthcare.

US states sue generic firms over ‘inflated’ prices

US states sue generic firms over ‘inflated’ prices

The legal action was filed on Friday by Connecticut Attorney General William Tong, and follows a five-year investigation into the alleged conspiracy to fix prices and allocate markets for more

Latest news

  • Gilead gets 'gold' in England's hepatitis C eradication drive Gilead gets 'gold' in England's hepatitis C eradication drive

    However, it ran into trouble when AbbVie mounted a legal action against NHSE, accusing it of of not treating all bidders fairly. ... programmes. NHS England has said, however, that the legal action delayed its plans by six months, and is now reluctant to

  • Leadiant gets FDA OK for bubble boy disease drug Leadiant gets FDA OK for bubble boy disease drug

    A non-profit health advocacy group in the Netherlands has launched legal action against the Italian drugmaker (formerly Sigma-Tau), accusing it of hiking the price of chenodeoxycholic acid (CDCA)

  • ABPI bid to overturn NICE’s budget impact rules fails ABPI bid to overturn NICE’s budget impact rules fails

    The Association of the British Pharmaceutical Industry (ABPI) has been fighting a legal action to try to overturn NICE’s introduction of a £20m cost ceiling for new drugs that have ... NHS England said in a statement that the High Court “has

  • New EU and US approvals for Humira biosimilars New EU and US approvals for Humira biosimilars

    AbbVie is claiming patent protection for Humira in the US out to 2022 and has already taken legal action to try to keep both Amjevita and Cyltezo off the market. ... Thus far, Amgen has opted not to launch its biosimilar 'at-risk' but is waiting to see

  • UK pharma launches legal challenge to NICE plans UK pharma launches legal challenge to NICE plans

    Applies for judicial review of budget impact test. The ABPI is taking legal action to try and block NICE’s forthcoming additional access hurdle for high-cost medicines. ... However, the ABPI’s action doesn’t appear to have unanimous industry backing

More from news
Approximately 9 fully matching, plus 56 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    Challenges. For treatments that fall outside of these schemes, there is an alternative route patients can go down to attempt to access them: legal action, via ‘recobros’. Given ‘right to healthcare’

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics